Testing effectiveness (Phase 2)UnknownNCT05313022
What this trial is testing
Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 84